Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China
· Delayed Price · Currency is CNY 33.94
-1.93 (-5.38%)
Feb 28, 2025, 2:44 PM CST
SHA:603882 Revenue
Guangzhou Kingmed Diagnostics Group had revenue of 2.02B CNY in the quarter ending September 30, 2024, a decrease of -16.61%. This brings the company's revenue in the last twelve months to 7.85B, down -18.05% year-over-year. In the year 2023, Guangzhou Kingmed Diagnostics Group had annual revenue of 8.54B, down -44.82%.
Revenue (ttm)
7.85B
Revenue Growth
-18.05%
P/S Ratio
2.13
Revenue / Employee
677.44K
Employees
11,586
Market Cap
16.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8.54B | -6.94B | -44.82% |
| Dec 31, 2022 | 15.48B | 3.53B | 29.58% |
| Dec 31, 2021 | 11.94B | 3.70B | 44.88% |
| Dec 31, 2020 | 8.24B | 2.97B | 56.45% |
| Dec 31, 2019 | 5.27B | 744.01M | 16.44% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Sichuan Biokin Pharmaceutical | 5.85B |